You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API TIRZEPATIDE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing TIRZEPATIDE

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	MOUNJARO	tirzepatide	0002-1506	HYDROCHLORIC ACID	2036-01-05
Eli Lilly and Company	MOUNJARO	tirzepatide	0002-1506	SODIUM CHLORIDE	2036-01-05
Eli Lilly and Company	MOUNJARO	tirzepatide	0002-1506	SODIUM HYDROXIDE	2036-01-05
Eli Lilly and Company	MOUNJARO	tirzepatide	0002-1506	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	2036-01-05
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for TIRZEPATIDE

Excipient focus: HYDROCHLORIC ACID

TIRZEPATIDE drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Eli Lilly and Company	tirzepatide	0002-1506
Eli Lilly and Company	tirzepatide	0002-2506
>Company	>Ingredient	>NDC

TIRZEPATIDE drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

TIRZEPATIDE drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Eli Lilly and Company	tirzepatide	0002-1506
Eli Lilly and Company	tirzepatide	0002-2506
>Company	>Ingredient	>NDC

TIRZEPATIDE drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

TIRZEPATIDE drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Eli Lilly and Company	tirzepatide	0002-1506
Eli Lilly and Company	tirzepatide	0002-2506
>Company	>Ingredient	>NDC

TIRZEPATIDE drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

TIRZEPATIDE drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Eli Lilly and Company	tirzepatide	0002-1506
Eli Lilly and Company	tirzepatide	0002-2506
>Company	>Ingredient	>NDC

TIRZEPATIDE drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

TIRZEPATIDE drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Eli Lilly and Company	tirzepatide	0002-1506
Eli Lilly and Company	tirzepatide	0002-2506
>Company	>Ingredient	>NDC

TIRZEPATIDE drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.